Yibing Wang
1 Minde Road
Nanchang, 330006, China
Nanchang, 330006, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Corrigendum: Downregulation of HMGA1 Mediates Autophagy and Inhibits Migration and Invasion in Bladder Cancer via miRNA-221/TP53INP1/p-ERK Axis.
Journal: Frontiers in oncology
Published: July 31, 2020
Development of an Immune-Related Risk Signature in Patients with Bladder Urothelial Carcinoma.
Journal: BioMed research international
Published: May 28, 2020
Downregulation of HMGA1 Mediates Autophagy and Inhibits Migration and Invasion in Bladder Cancer via miRNA-221/TP53INP1/p-ERK Axis.
Journal: Frontiers in oncology
Published: December 04, 2019
[Corrigendum] Celecoxib inhibits the epithelial‑to‑mesenchymal transition in bladder cancer via the miRNA‑145/TGFBR2/Smad3 axis.
Journal: International journal of molecular medicine
Published: March 01, 2019
Celecoxib inhibits the epithelial-to-mesenchymal transition in bladder cancer via the miRNA-145/TGFBR2/Smad3 axis.
Journal: International journal of molecular medicine
Published: March 01, 2019
CCL18 enhances migration, invasion and EMT by binding CCR8 in bladder cancer cells.
Journal: Molecular medicine reports
Published: May 14, 2018
MiR-221-induced PUMA silencing mediates immune evasion of bladder cancer cells.
Journal: International journal of oncology
Published: October 13, 2014
γ-Secretase inhibitor inhibits bladder cancer cell drug resistance and invasion by reducing epithelial-mesenchymal transition.
Journal: Molecular medicine reports
Published: June 05, 2014
Showing 1-11 of 11
Last Updated: 09/26/2026